📰 Mark Chin News
Page 2 - Mark Chin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mark Chin. Real-time updates on events, politics, business and more.
January 13, 2023
Tennessee public schools and universities would not be allowed to require employees to take "implicit bias" training under legislation filed this week by two state lawmakers.
January 10, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
June 15, 2022
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 479,800 shares, a growth of 37.9% from the May 15th total of 347,900 shares. Approximately 2.2% of the company’s shares are short sold. Based […]
June 2, 2022
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
May 27, 2022
Equities research analysts expect that Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) will announce earnings per share of ($0.68) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Pyxis Oncology’s earnings. The highest EPS estimate is ($0.51) and the lowest is ($0.84). The business is scheduled to issue its […]
May 16, 2022
Pyxis Oncology (NASDAQ:PYXS – Get Rating) posted its earnings results on Friday. The company reported ($0.97) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.36), MarketWatch Earnings reports. Shares of NASDAQ PYXS opened at $2.02 on Monday. Pyxis Oncology has a fifty-two week low of $2.00 and a fifty-two […]
April 25, 2022
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Rating) Director Mark Chin sold 1,745,761 shares of the company’s stock in a transaction on Thursday, April 21st. The shares were sold at an average price of $3.05, for a total transaction of $5,324,571.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which […]
December 22, 2021
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
December 22, 2021
Investegate announcements from Arix Bioscience PLC, Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals